Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

953 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke).
Shireman TI, Wang K, Saver JL, Goyal M, Bonafé A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Devlin TG, Lopes DK, Reddy VK, du Mesnil de Rochemont R, Jahan R, Vilain KA, House J, Lee JM, Cohen DJ; SWIFT-PRIME Investigators. Shireman TI, et al. Among authors: house j. Stroke. 2017 Feb;48(2):379-387. doi: 10.1161/STROKEAHA.116.014735. Epub 2016 Dec 27. Stroke. 2017. PMID: 28028150 Free PMC article. Clinical Trial.
Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding.
Amin AP, Marso SP, Rao SV, Messenger J, Chan PS, House J, Kennedy K, Robertus K, Cohen DJ, Mahoney EM. Amin AP, et al. Among authors: house j. Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):358-65. doi: 10.1161/CIRCOUTCOMES.110.957290. Epub 2010 May 20. Circ Cardiovasc Qual Outcomes. 2010. PMID: 20488917
Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
Baron SJ, Wang K, House JA, Magnuson EA, Reynolds MR, Makkar R, Herrmann HC, Kodali S, Thourani VH, Kapadia S, Svensson L, Mack MJ, Brown DL, Russo MJ, Smith CR, Webb J, Miller C, Leon MB, Cohen DJ. Baron SJ, et al. Among authors: house ja. Circulation. 2019 Feb 12;139(7):877-888. doi: 10.1161/CIRCULATIONAHA.118.035236. Circulation. 2019. PMID: 30586747 Clinical Trial.
Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
Frutkin AD, Lindsey JB, Mehta SK, House JA, Spertus JA, Cohen DJ, Rumsfeld JS, Marso SP; NCDR (National Cardiovascular Data Registry). Frutkin AD, et al. Among authors: house ja. JACC Cardiovasc Interv. 2009 Jul;2(7):614-21. doi: 10.1016/j.jcin.2009.05.001. JACC Cardiovasc Interv. 2009. PMID: 19628183 Free article.
Costs of transradial percutaneous coronary intervention.
Amin AP, House JA, Safley DM, Chhatriwalla AK, Giersiefen H, Bremer A, Hamon M, Baklanov DV, Aluko A, Wohns D, Mathias DW, Applegate RA, Cohen DJ, Marso SP. Amin AP, et al. Among authors: house ja. JACC Cardiovasc Interv. 2013 Aug;6(8):827-34. doi: 10.1016/j.jcin.2013.04.014. Epub 2013 Jul 17. JACC Cardiovasc Interv. 2013. PMID: 23871512 Free article.
Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.
Amin AP, Patterson M, House JA, Giersiefen H, Spertus JA, Baklanov DV, Chhatriwalla AK, Safley DM, Cohen DJ, Rao SV, Marso SP. Amin AP, et al. Among authors: house ja. JACC Cardiovasc Interv. 2017 Feb 27;10(4):342-351. doi: 10.1016/j.jcin.2016.11.049. JACC Cardiovasc Interv. 2017. PMID: 28231901 Free article.
953 results